KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 62 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $16,397,584 | +127.4% | 831,099 | +102.2% | 0.01% | +150.0% |
| Q4 2023 | $7,209,360 | -26.4% | 411,024 | -27.1% | 0.00% | -33.3% |
| Q3 2023 | $9,795,394 | +511.6% | 563,926 | +395.8% | 0.00% | +200.0% |
| Q2 2023 | $1,601,530 | +130744.0% | 113,745 | 0.0% | 0.00% | – |
| Q1 2023 | $1,224 | -47.0% | 113,745 | -26.3% | 0.00% | -100.0% |
| Q4 2022 | $2,311 | -99.8% | 154,318 | +49.3% | 0.00% | 0.0% |
| Q3 2022 | $1,328,000 | +26.7% | 103,387 | -4.4% | 0.00% | – |
| Q2 2022 | $1,048,000 | +8.5% | 108,154 | +15.1% | 0.00% | – |
| Q1 2022 | $966,000 | -23.5% | 93,978 | -12.4% | 0.00% | – |
| Q4 2021 | $1,263,000 | +0.8% | 107,309 | +4.4% | 0.00% | – |
| Q3 2021 | $1,253,000 | -13.0% | 102,816 | -0.6% | 0.00% | – |
| Q2 2021 | $1,441,000 | -15.3% | 103,486 | +12.6% | 0.00% | -100.0% |
| Q1 2021 | $1,702,000 | -77.5% | 91,943 | -78.6% | 0.00% | -66.7% |
| Q4 2020 | $7,580,000 | +11.3% | 429,003 | -3.5% | 0.00% | 0.0% |
| Q3 2020 | $6,812,000 | -18.8% | 444,629 | +35.1% | 0.00% | 0.0% |
| Q2 2020 | $8,386,000 | +103.5% | 329,102 | +23.6% | 0.00% | +50.0% |
| Q1 2020 | $4,120,000 | +907.3% | 266,187 | +620.0% | 0.00% | – |
| Q4 2019 | $409,000 | +17.9% | 36,970 | -9.3% | 0.00% | – |
| Q3 2019 | $347,000 | -33.4% | 40,740 | +5.8% | 0.00% | – |
| Q2 2019 | $521,000 | – | 38,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |